119 related articles for article (PubMed ID: 6647799)
1. [Tolerance induction by passage of the antigen with tumor cells].
Bundschuh G
Radiobiol Radiother (Berl); 1983; 24(4):525-30. PubMed ID: 6647799
[No Abstract] [Full Text] [Related]
2. Transplantability and antigenicity of two sublines of the TA3 tumor.
Sanford BH; Codington JF; Jeanloz RW; Palmer PD
J Immunol; 1973 May; 110(5):1233-7. PubMed ID: 4572632
[No Abstract] [Full Text] [Related]
3. Antigenicity of Ehrlich ascites through neuraminidase treatment of cells.
Sur P; Roy DK
Indian J Exp Biol; 1979 Sep; 17(9):953-5. PubMed ID: 544474
[No Abstract] [Full Text] [Related]
4. [Analysis of the antigenic specificity of cell subpopulations of Ehrlich ascites cancer].
Lobko GN; Porubova GM
Eksp Onkol; 1989; 11(1):69-71. PubMed ID: 2466634
[TBL] [Abstract][Full Text] [Related]
5. Effect of purine-protein conjugates on the Ehrlich ascites tumor in mice.
Lachman C; Cohen S
Cancer Res; 1970 Feb; 30(2):439-46. PubMed ID: 5441091
[No Abstract] [Full Text] [Related]
6. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
7. Antibody formation for malignant tumor. II. Antigenicity of Ehrlich ascites tumor lipoprotein.
Yamamoto Y; Tadatomo Y; Okamura S
Acta Med Okayama (1952); 1970 Oct; 24(5):527-36. PubMed ID: 4256471
[No Abstract] [Full Text] [Related]
8. Surface antigen on Ehrlich ascites tumor cells.
Pessina A; Brambilla P; Mocarelli P
Biomedicine; 1980; 33(4):105-9. PubMed ID: 7000194
[TBL] [Abstract][Full Text] [Related]
9. Natural cell-mediated cytotoxicity in Ehrlich ascites tumor-bearing mice.
Olinescu A; Hristescu S; Mazilu E
Neoplasma; 1983; 30(2):147-52. PubMed ID: 6843720
[TBL] [Abstract][Full Text] [Related]
10. Restoration of allograft immunity in tumor-bearing animals by "immune" RNA.
Rigby PG
J Lab Clin Med; 1968 May; 71(5):775-83. PubMed ID: 4869636
[No Abstract] [Full Text] [Related]
11. [Immunogenicity of cancer-associated and cancer-specific antigens].
del Pozo AM; Valladares Y; Alvarez-Rodríguez Y; Alvarez-Noves J
Rev Esp Oncol; 1982; 29(4):685-700. PubMed ID: 6927369
[TBL] [Abstract][Full Text] [Related]
12. Antitumor resistance activation in mice: can the immunological memory cells enhance resistance?
Kazmin SD; Todor IN; Chekhun VF
J Exp Clin Cancer Res; 2005 Dec; 24(4):585-93. PubMed ID: 16471321
[TBL] [Abstract][Full Text] [Related]
13. Cell fusion in the study of tumor cells.
Watkins JF
Int Rev Exp Pathol; 1971; 10():115-41. PubMed ID: 4945805
[No Abstract] [Full Text] [Related]
14. Epidermal cell presentation of tumor-associated antigens for induction of tolerance.
Tan KC; Hosoi J; Grabbe S; Asahina A; Granstein RD
J Immunol; 1994 Jul; 153(2):760-7. PubMed ID: 7912706
[TBL] [Abstract][Full Text] [Related]
15. The effect of immune organ transplants on homograft rejection in tumor-bearing mice.
Rigby PG
J Lab Clin Med; 1967 May; 69(5):800-9. PubMed ID: 5337458
[No Abstract] [Full Text] [Related]
16. Growth of subcutaneous grafts of some clones of Ehrlich ascites tumor in mice of different strains.
Bregula U; Slowikowska G; Dux K
Arch Immunol Ther Exp (Warsz); 1966; 14(6):711-6. PubMed ID: 5957992
[No Abstract] [Full Text] [Related]
17. [Antineoplastic immunological reactions in animals with Ehrlich's carcinoma].
Bergamini G; D'Acunzo L; Fazio G; Giudici G
Riv Patol Clin Sper; 1967; 8(4):477-88. PubMed ID: 5605966
[No Abstract] [Full Text] [Related]
18. Effect of cyclophosphamide on tumor cell sensitivity to the action of immunological effectors.
Culo F; Marić M; Morović-Vergles J
In Vivo; 1995; 9(5):439-46. PubMed ID: 8900921
[TBL] [Abstract][Full Text] [Related]
19. Induction of resistance to Ehrlich tumoural grafts with the aid of viruses cultivated "in vivo" in homologous tumour.
Nastac E; Alexandrescu D; Hozoc M; Stoian M
Rev Roum Inframicrobiol; 1971; 8(2):83-9. PubMed ID: 5164571
[No Abstract] [Full Text] [Related]
20. Extra-lymphatic solid tumor growth is not immunologically ignored and results in early induction of antigen-specific T-cell anergy: dominant role of cross-tolerance to tumor antigens.
Cuenca A; Cheng F; Wang H; Brayer J; Horna P; Gu L; Bien H; Borrello IM; Levitsky HI; Sotomayor EM
Cancer Res; 2003 Dec; 63(24):9007-15. PubMed ID: 14695219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
